ELOCTATE 1000
国家: 以色列
语言: 英文
来源: Ministry of Health
该产品的某些文档当前不可用，您可以向我们的客户服务发送请求，我们将在获得它们后尽快通知您。
发送请求。
发送请求。
有效成分:
COAGULATION FACTOR VIII
可用日期:
SANOFI - AVENTIS ISRAEL LTD
ATC代码:
B02BD05
药物剂型:
POWDER AND SOLVENT FOR SOLUTION FOR INJECTION
组成:
COAGULATION FACTOR VIII 1000 IU
给药途径:
I.V
处方类型:
Required
厂商:
BIOGEN IDEC LIMITED , UK
治疗领域:
COAGULATION FACTOR VII
疗效迹象:
ELOCTATE [Antihemophilic Factor (Recombinant Fc Fusion Protein)] is a long-acting antihemophilic factor (recombinant) indicated in adults and children12 years of age and older with Hemophilia A (congenital factor VIII deficiency) for:• Control and prevention of bleeding episodes.• Routine prophylaxis to prevent or reduce the frequency of bleeding episodes.• Perioperative management (surgical prophylaxis).ELOCTATE is not indicated for the treatment of von Willebrand disease.
授权日期:
2017-01-09
